Key result
Elevated serum ISG15 is linked to ~21% higher odds of hypertriglyceridemia.
Why the study?
Are elevated serum levels of interferon-stimulated gene 15 (ISG15) associated with the prevalence of hypertriglyceridemia in Chinese adults?
Case-Control (n=295)
Are elevated serum levels of interferon-stimulated gene 15 (ISG15) associated with the prevalence of hypertriglyceridemia in Chinese adults?
Answers are grounded in this paper and cite their sources.
Serum ISG15 is independently and nonlinearly associated with hypertriglyceridemia in humans and elevated in adipose and liver tissues of high-fat diet-fed mice, suggesting its potential as a diagnostic biomarker in dyslipidemia.
Hypertriglyceridemia (HTG) is a prevalent dyslipidemia worldwide and an independent risk factor for cardiovascular disease and acute pancreatitis. Interferon-stimulated gene 15 (ISG15), a ubiquitin-like protein involved in innate immunity, has recently been implicated in metabolic disorders, but its relationship with HTG remains unexplored. This study included 295 Chinese participants (184 with HTG and 111 without HTG). Serum ISG15 levels were measured by enzyme-linked immunosorbent assay, and associations with HTG were assessed using logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curves. Findings were validated in high-fat diet (HFD)-induced HTG mouse through western blotting, immunohistochemistry, and histological analyses. Serum ISG15 levels were significantly elevated in HTG patients compared with controls (3.18 ± 0.29 vs. 1.64 ± 0.19, P < 0.001). Multivariate logistic regression identified ISG15 as an independent predictor of HTG (OR: 1.214, 95% CI: 1.015-1.416, P = 0.033). RCS analysis revealed a nonlinear dose-response relationship with an inflection point at approximately 1.52 ng/mL. ROC analysis demonstrated good diagnostic performance (AUC: 0.697, sensitivity: 86.40%, specificity: 45.00% at cut-off 0.873 ng/mL). In HFD-fed mice, serum ISG15 levels were significantly elevated, and immunohistochemistry and western blotting confirmed increased ISG15 expression in liver, subcutaneous white adipose tissue, and epididymal white adipose tissue. ISG15 is independently associated with HTG and exhibits a nonlinear relationship with diagnostic potential. These findings establish ISG15 as a potential biomarker and suggest its involvement in the immunometabolic crosstalk underlying HTG pathogenesis, warranting further mechanistic investigation.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted a case-control in Hypertriglyceridemia (n=295). Serum interferon-stimulated gene 15 (ISG15) levels vs. Participants without hypertriglyceridemia (controls) was evaluated on Prevalence of hypertriglyceridemia (OR 1.214, 95% CI 1.015-1.416, p=0.033). Serum ISG15 levels were independently associated with hypertriglyceridemia and elevated vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: